You are viewing the site in preview mode

Skip to main content

Table 4 Number and frequency of every HLA-B allele found in our population for each group

From: HLA-B*35 as a new marker for susceptibility to human T-cell lymphotropic virus type 1 (HTLV-1) Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) in patients living in Argentina

B Population Overall Allele frequency
NII AC ATLL HAM
HLA-B*07 1 2 0 0 3 0.027
HLA-B*08 2 2 0 3 7 0.063
HLA-B*13 0 0 0 1 1 0.009
HLA-B*14 2 2 1 2 7 0.063
HLA-B*15 0 0 0 2 2 0.018
HLA-B*18 0 0 2 0 2 0.018
HLA-B*27 2 0 0 0 2 0.018
HLA-B*35 8 2 3 15 28 0.25
HLA-B*38 4 4 0 0 8 0.071
HLA-B*39 5 4 4 2 15 0.134
HLA-B*40 2 0 0 0 2 0.018
HLA-B*41 0 0 0 1 1 0.009
HLA-B*44 0 2 1 1 4 0.036
HLA-B*48 0 8 0 0 8 0.071
HLA-B*49 0 0 0 1 1 0.009
HLA-B*51 0 3 2 5 10 0.089
HLA-B*52 0 2 0 2 4 0.036
HLA-B*53 0 6 0 0 6 0.054
HLA-B*55 0 0 0 1 1 0.009
Overall 26 37 13 36 112 1
  1. NII non infected individual, AC Asymptomatic Carrier, ATLL Adult T cell leukemia/lymphoma, HAM HTLV-1- associated myelopathy